Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125184122 | 12518412 | 2 | F | 20160227 | 20160804 | 20160630 | 20160816 | EXP | ES-PFIZER INC-2016149098 | PFIZER | 71.00 | YR | M | Y | 81.00000 | KG | 20160816 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125184122 | 12518412 | 1 | PS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | 137.25 MG, CYCLIC(ONCE EVERY 3 WEEKS) | 305370 | 22234 | 137.25 | MG | SOLUTION FOR INJECTION | ||||||
| 125184122 | 12518412 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | UNK | 305376 | 22234 | SOLUTION FOR INJECTION | |||||||||
| 125184122 | 12518412 | 3 | C | ATORVASTATINA | ATORVASTATIN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 125184122 | 12518412 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
| 125184122 | 12518412 | 5 | C | DOMPERIDONE | DOMPERIDONE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 125184122 | 12518412 | 6 | C | DOMPERIDONE | DOMPERIDONE | 1 | 0 | ||||||||||||
| 125184122 | 12518412 | 7 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, UNK | 0 | 50 | MG | ||||||||
| 125184122 | 12518412 | 8 | C | MYCOSTATIN | NYSTATIN | 1 | Oral | 9 CC | 0 | ||||||||||
| 125184122 | 12518412 | 9 | C | ALMAGATE | ALMAGATE | 1 | Oral | 1.5 MG, 3X/DAY | 0 | 1.5 | MG | TID | |||||||
| 125184122 | 12518412 | 10 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 4 MG, 2X/DAY | 232 | MG | 0 | 4 | MG | BID | |||||
| 125184122 | 12518412 | 11 | C | GRANISETRON | GRANISETRON | 1 | Oral | 1 MG, 2X/DAY | 0 | 1 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125184122 | 12518412 | 1 | Non-small cell lung cancer |
| 125184122 | 12518412 | 3 | Dyslipidaemia |
| 125184122 | 12518412 | 4 | Gastritis prophylaxis |
| 125184122 | 12518412 | 5 | Nausea |
| 125184122 | 12518412 | 6 | Vomiting |
| 125184122 | 12518412 | 7 | Arthralgia |
| 125184122 | 12518412 | 8 | Prophylaxis |
| 125184122 | 12518412 | 9 | Gastritis prophylaxis |
| 125184122 | 12518412 | 10 | Prophylaxis of nausea and vomiting |
| 125184122 | 12518412 | 11 | Chemotherapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125184122 | 12518412 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125184122 | 12518412 | Neutropenia | |
| 125184122 | 12518412 | Respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125184122 | 12518412 | 1 | 20160129 | 0 | ||
| 125184122 | 12518412 | 4 | 20160119 | 0 | ||
| 125184122 | 12518412 | 9 | 20160119 | 0 | ||
| 125184122 | 12518412 | 10 | 20160130 | 20160408 | 0 | |
| 125184122 | 12518412 | 11 | 20160129 | 0 |